The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Ridsdale, Andrew John
    Managing Director born in March 1971
    Individual (2 offsprings)
    Officer
    2022-05-23 ~ now
    OF - Director → CIF 0
  • 2
    Seelenfreund, Yigal
    Vp International Sales & Marketing born in August 1967
    Individual (2 offsprings)
    Officer
    2022-05-23 ~ now
    OF - Director → CIF 0
  • 3
    Konstantinou, Anastasis
    Director born in July 1984
    Individual (3 offsprings)
    Officer
    2014-06-24 ~ now
    OF - Director → CIF 0
  • 4
    1, Dexcel St, Or-akiva, Israel
    Corporate (1 offspring)
    Person with significant control
    2016-12-19 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
Ceased 9
  • 1
    Avraham, Dov
    Vice President born in September 1968
    Individual
    Officer
    2010-11-01 ~ 2014-06-24
    OF - Director → CIF 0
  • 2
    Flippance, Brian John
    Individual
    Officer
    2011-09-26 ~ 2013-12-05
    OF - Secretary → CIF 0
  • 3
    Grigg, Terry
    Company Director born in January 1949
    Individual (1 offspring)
    Officer
    2006-12-19 ~ 2022-05-23
    OF - Director → CIF 0
    Grigg, Terry Kenneth
    Individual (1 offspring)
    Officer
    2013-12-05 ~ 2022-05-23
    OF - Secretary → CIF 0
  • 4
    Seelenfreund, Ygal
    Vp International Sales born in August 1967
    Individual (2 offsprings)
    Officer
    2006-12-19 ~ 2008-10-27
    OF - Director → CIF 0
  • 5
    Carmeli, Liel
    Cfo born in September 1964
    Individual
    Officer
    2006-12-19 ~ 2010-11-01
    OF - Director → CIF 0
  • 6
    Kappler, Michael Roy
    Company Director born in September 1948
    Individual (1 offspring)
    Officer
    2006-12-19 ~ 2010-05-10
    OF - Director → CIF 0
  • 7
    Whatsize, Sarah
    Company Director born in January 1981
    Individual
    Officer
    2006-12-19 ~ 2010-11-22
    OF - Director → CIF 0
    Whatsize, Sarah
    Company Director
    Individual
    Officer
    2006-12-19 ~ 2010-11-22
    OF - Secretary → CIF 0
  • 8
    4th Floor, Lawford House Albert Place, London
    Dissolved Corporate (1 parent, 5 offsprings)
    Officer
    2006-12-19 ~ 2006-12-19
    PE - Director → CIF 0
  • 9
    4th Floor Lawford House, Albert Place, London
    Dissolved Corporate (1 parent, 306 offsprings)
    Officer
    2006-12-19 ~ 2006-12-19
    PE - Secretary → CIF 0
parent relation
Company in focus

DEXCEL-PHARMA LABORATORIES LIMITED

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Fixed Assets - Investments
6,751,063 GBP2023-06-30
2 GBP2021-12-31
Fixed Assets
6,751,063 GBP2023-06-30
2 GBP2021-12-31
Debtors
Current
458,598 GBP2023-06-30
458,325 GBP2021-12-31
Cash at bank and in hand
63,327 GBP2023-06-30
64,077 GBP2021-12-31
Current Assets
521,925 GBP2023-06-30
522,402 GBP2021-12-31
Creditors
Current, Amounts falling due within one year
-168,357 GBP2023-06-30
-162,811 GBP2021-12-31
Net Current Assets/Liabilities
353,568 GBP2023-06-30
359,591 GBP2021-12-31
Total Assets Less Current Liabilities
7,104,631 GBP2023-06-30
359,593 GBP2021-12-31
Net Assets/Liabilities
7,104,631 GBP2023-06-30
359,593 GBP2021-12-31
Equity
Called up share capital
2 GBP2023-06-30
2 GBP2021-12-31
2 GBP2021-01-01
Other miscellaneous reserve
12,365,015 GBP2023-06-30
Retained earnings (accumulated losses)
-5,260,386 GBP2023-06-30
359,591 GBP2021-12-31
366,208 GBP2021-01-01
Equity
7,104,631 GBP2023-06-30
359,593 GBP2021-12-31
366,210 GBP2021-01-01
Profit/Loss
Retained earnings (accumulated losses)
-5,619,977 GBP2022-01-01 ~ 2023-06-30
-6,617 GBP2021-01-01 ~ 2021-12-31
Average Number of Employees
212022-01-01 ~ 2023-06-30
212021-01-01 ~ 2021-12-31
Investments in Subsidiaries
2 GBP2023-06-30
2 GBP2021-12-31
Amounts Owed by Group Undertakings
Current
458,325 GBP2023-06-30
458,325 GBP2021-12-31
Other Debtors
Current
273 GBP2023-06-30
Cash and Cash Equivalents
63,327 GBP2023-06-30
64,077 GBP2021-12-31
Amounts owed to group undertakings
Current
158,607 GBP2023-06-30
152,902 GBP2021-12-31
Corporation Tax Payable
Current
159 GBP2021-12-31
Accrued Liabilities/Deferred Income
Current
9,750 GBP2023-06-30
9,750 GBP2021-12-31
Creditors
Current
168,357 GBP2023-06-30
162,811 GBP2021-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2 shares2023-06-30
2 shares2021-12-31
Par Value of Share
Class 1 ordinary share
1.002022-01-01 ~ 2023-06-30

Related profiles found in government register
  • DEXCEL-PHARMA LABORATORIES LIMITED
    Info
    Registered number 06033065
    7 Sopwith Way, Drayton Fields Industrial Estate, Daventry NN11 8PB
    Private Limited Company incorporated on 2006-12-19 (18 years 6 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-05
    CIF 0
  • DEXCEL PHARMA LABORATORIES LTD
    S
    Registered number missing
    Ashacres House, Draycott-in-the-clay, Ashbourne, England, DE6 5GX
    Limited Company
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • 7 Sopwith Way, Drayton Fields Industrial Estate, Daventry, Northamptonshire
    Active Corporate (4 parents, 1 offspring)
    Equity (Company account)
    14,160,928 GBP2023-06-30
    Person with significant control
    2016-08-23 ~ now
    CIF 1 - Ownership of shares – 75% or moreOE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.